Chlamydia: Symptoms, Risks, and Testing

Chlamydia is the most frequently reported sexually transmitted infection in the United States, with more than 1.6 million cases documented in 2023. The infection is caused by the bacterium Chlamydia trachomatis and can affect individuals of any age, though younger adults are disproportionately impacted.

What makes chlamydia particularly challenging from a public health perspective is its tendency to produce no symptoms. Data from community screening programs indicate that up to 77% of chlamydial infections are asymptomatic, meaning the majority of infected individuals are unaware they are carrying and potentially transmitting the bacteria. Despite the absence of obvious symptoms, untreated chlamydia can cause serious complications, including permanent damage to the reproductive system that may result in infertility. This combination of silent transmission and potentially serious consequences makes regular screening one of the most important tools for controlling the infection.

Chlamydia spreads through sexual contact when vaginal fluid or semen containing the bacteria passes from one person to another during vaginal, anal, or oral sex without a barrier method. Sharing sex toys with an infected partner can also transmit the infection.

Several factors increase susceptibility. Individuals under 25 are at elevated risk, as are those with new or multiple sexual partners, people who do not use condoms consistently, and anyone with a prior history of chlamydia or other STIs. Adolescent and young adult women face particularly high risk because cervical tissue is not yet fully matured, making it more vulnerable to infection. Higher transmission rates in certain communities often reflect structural factors such as limited access to STI prevention resources, sexual health education, and barrier protection.

Because the majority of chlamydia infections produce no symptoms, screening is recommended even in the absence of any signs of infection. CDC guidelines recommend annual testing for all sexually active women under 25, and for women 25 and older who have risk factors such as new or multiple sexual partners.

Men who have sex with men should be screened at least annually, with more frequent testing for those with multiple partners. Anyone who develops symptoms suggestive of chlamydia, or whose partner has been diagnosed with an STI, should seek testing promptly. Because reinfection is common, retesting approximately three months after completing treatment is recommended even when partners have also been treated.

Nucleic acid amplification tests (NAAT) are the gold standard for chlamydia diagnosis, using urine samples or swabs from genital, anal, or throat sites depending on exposure history. A positive result indicates an active infection requiring antibiotic treatment. Because chlamydia and gonorrhea coinfection is common, a positive result for one often prompts testing or treatment for the other.

A negative result generally means no chlamydia was detected at the time of testing, though a brief window period between infection and detectability exists. After treatment, retesting at approximately three months is standard practice because reinfection rates are significant. Self-collected samples produce results comparable to clinician-collected specimens, making testing accessible and convenient without requiring an in-office procedure.

The most reliable prevention strategy is abstinence from sexual contact or maintaining a long-term mutually monogamous relationship with a partner confirmed to be uninfected. For sexually active individuals, consistent and correct use of latex condoms significantly reduces chlamydia transmission risk.

Access to sexual health education and barrier methods plays an important role in preventing the spread of chlamydia at the community level. The reassuring aspect of a chlamydia diagnosis is that the infection is readily cured with antibiotics, and early treatment prevents the long-term complications that untreated infection can cause. Completing the full prescribed course of medication is essential to ensure the bacteria are completely eliminated and to reduce the risk of reinfection or complications.